Dated Feb 10, 2023
SII's cervical cancer vaccine in market this month
New Delhi: The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per vial of two doses, official sources said on Thursday.
The first indigenous human papillomavirus (HPV) vaccine was launched by Union Home Minister Amit Shah on January 24 in the presence of Serum Institute of India
(SII) CEO Adar Poonawalla and its Director of Government and Regulatory Affairs Prakash Kumar Singh.